MARKET TALK: Genmab Closes Up On Renewed Bid Speculation

18th Jun 2010 16:21

1521 GMT [Dow Jones] Genmab (GEN.KO) closes +19% at DKK61 amid renewed speculation that partner GlaxoSmithKline (GSK) could place a bid for the company, says Sydbank's head of Scandinavian equities Ole Jensen. Says the stock has been very volatile since CEO Drakeman unexpectedly left the company earlier this week. Shares in Genmab fell earlier in the week as investors interpreted the CEO's exit as an indication that a bid from GlaxoSmithKline was unlikely. Press spokespersons from Genmab and GlaxoSmithKline earlier declined to comment on any bid speculation. ([email protected]) Contact us in London. +44-20-7842-9464 [email protected] (END) Dow Jones Newswires June 18, 2010 11:21 ET (15:21 GMT)

Top Risers

Share	Price	Change
Huddled Group (HUD)	0.85	24.14%
Eurasia Mining (EUA)	2.80	19.15%
Genincode (GENI)	0.725	16%
Medpal AI (MPAL)	5.25	14.13%
Light Science Technologies (LST)	0.875	12.9%

Top Fallers

Share	Price	Change
Catenai Plc (CTAI)	0.0575	-39.47%
Petra Diamonds (PDL)	2.60	-26.14%
Focus Xplore (FOX)	0.019	-22.45%
Litigation Cap. (LIT)	0.301	-20.12%
Abrdn Property (API)	1.52	-15.56%

Top By Volume

Share	Price	Volume
Ethernity Net (ENET)	0.0019	1,922,336,250
Forgent (FORG)	0.0115	591,087,829
Premier African Minerals (PREM)	0.0044	313,776,718
Focus Xplore (FOX)	0.019	253,421,870
Bezant Resources PLC (BZT)	0.11	246,929,868

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.